Clinical Trial Update: Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Samarium Sm-153 and stem cell transplant followed by radiation therapy in patients with osteosarcoma (sarcoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Sarcoma

Drugs mentioned

• Samarium Sm-153 (samarium-153)
• Stem cell transplant

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2015-05-01